Dr. rer. nat. Alina Hartmann

Facts

Phone: +49 176 321 99 550
E-Mail: alina.hartmann@uksh.de
Affiliations: Clinic for Internal Medicine II, Hematology and Oncology / University Medical Center Schleswig-Holstein, Campus Kiel

Curriculum vitae

Education/Training

08/2020Obtained the doctoral degree (magna cum laude), awarded by the Christian-Albrechts-University in Kiel
01/2016 – 01/2020Doctoral thesis at the Max Planck Institute for Evolutionary Biology in Plön, Department of Evolutionary Genetics
10/2013 – 02/2016Master’s degree Humboldt University Berlin, Molecular Life Sciences (Biology)

Research groups

Project-related publications

P1, P3, P4, INF, Z

UBTF::ATXN7L3 gene fusion defines novel B cell precursor ALL subtype with CDX2 expression and need for intensified treatment

Bastian L, Hartmann AM, Beder T, Hänzelmann S, Kässens J, Bultmann M, Hoeppner MP, Franzenburg S, Wittig M, Franke F, Nagel I, Spielmann M, Reimer N, Busch H, Schwartz S, Steffen B, Viardot A, Döhner K, Kondakci M, Wulf G,  Wendelin K, Renzelmann A, Kiani A, Trautmann H, Neumann M, Gökbuget N, Brüggemann M, Baldus CD

PubMed (PMID: 35397658)
Leukemia
2022
P1, P4, INF

IRF4 deficiency vulnerates B-cell progeny for leukemogenesis via somatically acquired Jak3 mutations conferring IL-7 hypersensitivity

Das Gupta D, Paul C, Samel N, Bieringer M, Staudenraus D, Marini F, Raifer H, Menke L, Hansal L, Camara B, Roth E,  Daum P, Wanzel M, Mernberger M, Nist A, Bauer UM, Helmprobst F, Buchholz M, Roth K, Bastian L, Hartmann AM, Baldus C, Ikuta K, Neubauer A, Burchert A, Jäck HM, Klein M, Bopp T, Stiewe T, Pagenstecher A, Lohoff M

PubMed (PMID: 35459909)
Cell Death Differ.
2022

Participating Institutes